Stratos Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.94M | Sell |
35,268
-400
| -1% | -$22K | 0.1% | 208 |
|
|
2025
Q1 | $2.52M | Sell |
35,668
-7,774
| -18% | -$550K | 0.14% | 143 |
|
|
2024
Q4 | $2.86M | Sell |
43,442
-400
| -0.9% | -$26.3K | 0.14% | 154 |
|
|
2024
Q3 | $3.08M | Sell |
43,842
-2,022
| -4% | -$142K | 0.14% | 157 |
|
|
2024
Q2 | $3.78M | Hold |
45,864
| – | – | 0.19% | 122 |
|
|
2024
Q1 | $4.01M | Hold |
45,864
| – | – | 0.24% | 102 |
|
|
2023
Q4 | $4.42M | Hold |
45,864
| – | – | 0.25% | 113 |
|
|
2023
Q3 | $4.06M | Sell |
45,864
-2,550
| -5% | -$226K | 0.27% | 105 |
|
|
2023
Q2 | $4.2M | Buy |
48,414
+1,600
| +3% | +$139K | 0.3% | 92 |
|
|
2023
Q1 | $4.55M | Buy |
46,814
+9,755
| +26% | +$949K | 0.35% | 79 |
|
|
2022
Q4 | $3.84M | Buy |
+37,059
| New | +$3.84M | 0.32% | 92 |
|